Related Experiment Video
Updated: Mar 15, 2026

A Functional Assay for Gap Junctional Examination; Electroporation of Adherent Cells on Indium-Tin Oxide
Published on: October 18, 2014
Eupatilin inhibits EGF-induced JB6 cell transformation by targeting PI3K
1Department of Pathophysiology, Basic Medical College, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China.
Abstract:
Phosphatidylinositol 3-kinases (PI3Ks) are lipid kinases that play fundamental roles in regulation of multiple signaling pathways, including cell proliferation, survival and cell cycle. Increasing evidence has shown that abnormal activation of PI3K pathway contributes to tumorigenesis and progression of various malignant tumors. Therefore, it is an attractive target of chemoprevention and chemotherapy. Eupatilin, a natural flavone compound extracted from Artemisia vulgaris, has antitumor and anti-inflammation efficacy. However, the direct target(s) of eupatilin in cancer chemoprevention are still elusive. In the present study, we reported eupatilin suppressed JB6 cell proliferation and its EGF-induced colony formation. Eupatilin attenuated phosphorylation of PI3K downstream signaling molecules. Downregulation of cyclin D1 expression and arresting in G1 phase were induced through eupatilin treatment. Furthermore, we found it could bind to the p110α, a catalytic subunit of PI3K, by computational docking methods. Pull down assay outcomes also verified the binding of eupatilin with PI3K. Taken together, our results suggest that epatilin is a potential chemopreventive agent in inhibition of skin cell transformation by targeting PI3K.
Insights
Eupatilin, a natural compound, inhibits skin cell transformation by targeting Phosphatidylinositol 3-kinases (PI3Ks). This study reveals eupatilin
Area of Science:
- Oncology
- Pharmacology
- Biochemistry
Background:
- Phosphatidylinositol 3-kinases (PI3Ks) are crucial in cell signaling pathways.
- Aberrant PI3K pathway activation is linked to cancer development and progression.
- PI3K is a significant target for cancer chemoprevention and chemotherapy.
Purpose of the Study:
- To investigate the direct molecular targets of eupatilin, a natural flavone, in cancer chemoprevention.
- To determine if eupatilin can inhibit skin cell transformation.
- To elucidate the mechanism by which eupatilin exerts its antitumor effects.
Main Methods:
- Cell proliferation and colony formation assays using JB6 cells.
- Western blotting to assess PI3K downstream signaling.
- Computational docking and pull-down assays to identify eupatilin's binding target.
- Cell cycle analysis.
Main Results:
- Eupatilin suppressed JB6 cell proliferation and epidermal growth factor-induced colony formation.
- Eupatilin treatment reduced phosphorylation of PI3K downstream signaling molecules.
- Eupatilin induced G1 phase cell cycle arrest and downregulated cyclin D1 expression.
- Computational and experimental assays confirmed eupatilin binds to the p110α catalytic subunit of PI3K.
Conclusions:
- Eupatilin demonstrates potential as a chemopreventive agent against skin cell transformation.
- The mechanism involves targeting and inhibiting the PI3K pathway.
- Eupatilin's direct binding to PI3K's p110α subunit underlies its observed effects.
Related Concept Videos
The JAK-STAT Signaling Pathway
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Mitogens and the Cell Cycle
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Intracellular Signaling Affects Focal Adhesions
Some...

